Is a Massive S&P 500 Sell-Off Starting? – Buy 4 Safe Passive Income Dividend Stocks Now24/7 Wall Street • 07/19/24
Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular CarcinomaBusiness Wire • 07/19/24
Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 StocksThe Motley Fool • 07/18/24
Is Bristol-Myers Squibb's Rich Dividend Yield Worth The Patent Cliff Correction Risk?Seeking Alpha • 07/17/24
Dividend Harvesting Portfolio Week 175: $17,500 Allocated, $1,566.24 In Projected DividendsSeeking Alpha • 07/11/24
Want $1,000 in Reliable Dividend Income? Invest $11,800 in these 3 Ultra-High-Yield Dividend Stocks.The Motley Fool • 07/10/24
Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation DayBusiness Wire • 07/08/24
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in JulyThe Motley Fool • 07/06/24